Oxidised-HDL3 induces the expression of PAI-1 in human endothelial cells. Role of p38MAPK activation and mRNA stabilization

British Journal of Haematology

Volumn 127, Issue 1, 2004, Pages 97-104

  Norata, Giuseppe Danilo ^a   Banfi, Cristina ^a,b   Pirillo, Angela ^a   Tremoli, Elena ^a,b   Hamsten, Anders ^c   Catapano, Alberico L ^a,d   Eriksson, Per ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Ospedale Bassini   (Italy)

Author keywords

Atherosclerosis; Kinase; Lipoproteins; Oxidative modification; Thrombosis

Indexed keywords

ANTIGEN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED HIGH DENSITY LIPOPROTEIN 3; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG; HIGH DENSITY LIPOPROTEIN 3;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; RNA STABILITY; THROMBOSIS; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; OXIDATION REDUCTION REACTION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL3; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 4944257390     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05163.x     Document Type: Article

References (32)

1. Banfi, C., Mussoni, L., Ris, P., Cattaneo, M.G., Vicentini, L., Battaini, F., Galli, C. & Tremoli, E. (1999) Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells. Circulation Research, 85, 208-217.
2. Banfi, C., Eriksson, P., Giandomenico, G., Mussoni, L., Sironi, L., Hamsten, A. & Tremoli, E. (2001) Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway. Diabetes, 50, 1522-1530.
3. Banfi, C., Auwerx, J., Poma, F., Tremoli, E. & Mussoni, L. (2003) Induction of plasminogen activator inhibitor I by the PPARalpha ligand, Wy-14,643, is dependent on ERK1/2 signaling pathway. Thrombosis and Haemostasis, 90, 611-619.
4. Calabresi, L., Gomaraschi, M. & Franceschini, G. (2003) Endothelial protection by high-density lipoproteins: from bench to bedside. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1724-1731.
5. Chen, Y., Billadello, J.J. & Schneider, D.J. (2000) Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 2696-2701.
6. Chin, J.H., Azhar, S. & Hoffman, B.B. (1992) Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. Journal of Clinical Investigation, 89, 10-18.
7. Eriksson, P., Nilsson, L., Karpe, F. & Hamsten, A. (1998) Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 20-26.
8. Francis, G.A. (2000) High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochimica et Biophysica Acta, 1483, 217-235.
9. Heaton, J.H., Dlakic, W.M. & Gelehrter, T.D. (2003) Posttranscriptional regulation of PAI-1 gene expression. Thrombosis and Haemostasis, 89, 959-966.
10. Hou, B., Eren, M., Painter, C.A., Covington, J.W., Dixon, J.D., Schoenhard, J.A. & Vaughan, D.E. (2004) Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. Journal of Biological Chemistry, 279, 18127-18136.
11. Huber, K., Christ, G., Wojta, J. & Gulba, D. (2001) Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. Thrombosis Research, 103(Suppl. 1), S7-S19.
12. Inoue, H., Taba, Y., Miwa, Y., Yokota, C., Miyagi, M. & Sasaguri, T. (2002) Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1415-1420.
13. Iwai-Kanai, E., Hasegawa, K., Sawamura, T., Fujita, M., Yanazume, T., Toyokuni, S., Adachi, S., Kihara, Y. & Sasayama, S. (2001) Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes. Circulation, 104, 2948-2954.
14. Kietzmann, T., Jungermann, K. & Gorlach, A. (2003) Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thrombosis and Haemostasis, 89, 666-673.
15. Kohler, H.P. & Grant, P.J. (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. New England Journal of Medicine, 342, 1792-1801.
16. Marsche, G., Levak-Frank, S., Quehenberger, O., Heller, R., Sattler, W. & Malle, E. (2001) Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. FASEB Journal, 15, 1095-1097.
17. Matsunaga, T., Hokari, S., Koyama, I., Harada, T. & Komoda, T. (2003) NF-kappa B activation in endothelial cells treated with oxidized high-density lipoprotein. Biochemical and Biophysical Research Communications, 303, 313-319.
18. Nagano, Y., Arai, H. & Kita, T. (1991) High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proceedings of the National Academy of Sciences of the United States of America, 88, 6457-6461.
19. Nakajima, T., Origuchi, N., Matsunaga, T., Kawai, S., Hokari, S., Nakamura, H., Inoue, I., Katayama, S., Nagata, A. & Komoda, T. (2000) Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Annals of Clinical Biochemistry, 37, 179-186.
20. Nofer, J.R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G. & von Eckardstein, A. (2002) HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis, 161, 1-16.
21. 3 on the expression of matrix-degrading proteases in human endothelial cells. International Journal of Molecular Medicine, 12, 73-78.
22. Norata, G.D., Pirillo, A., Callegari, E., Hamsten, A., Catapano, A.L. & Eriksson, P. (2003b) Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovascular Research, 59, 169-180.
23. Norata, G.D., Bjork, H., Hamsten, A., Catapano, A.L. & Eriksson, P. (2004a) High-density lipoprotein subfraction 3 decreases ADAMTS-1 expression induced by lipopolysaccharide and tumor necrosis factor-alpha in human endothelial cells. Matrix Biology, 22, 557-560.
24. 3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 871-877.
25. Nuszkowski, A., Grabner, R., Marsche, G., Unbehaun, A., Malle, E. & Heller, R. (2001) Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase. Journal of Biological Chemistry, 276, 14212-14221.
26. Pirillo, A., Norata, G.D., Zanelli, T. & Catapano, A.L. (2001) Overexpression of inducible heat shock protein 70 in Cos-1 cells fails to protect from cytotoxicity of oxidized ldls. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 348-354.
27. Providence, K.M., White, L.A., Tang, J., Conclaves, J., Staiano-Coico, L. & Higgins, P.J. (2002) Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene. Journal of Cell Science, 115, 3767-3777.
28. Salmon, S., Santus, R., Maziere, J.C., Aubailly, M. & Haigle, J. (1992) Modified apolipoprotein pattern after irradiation of human high-density lipoproteins by ultraviolet B. Biochimica et Biophysica Acta, 1128, 167-173.
29. Sambrook, J, Fritsch, F.E. & Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York.
30. Sironi, L., Mussoni, L., Prati, L., Baldassarre, D., Camera, M., Banfi, C. & Tremoli, E. (1996) Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 89-96.
31. Thomas, M.J., Chen, Q., Zabalawi, M., Anderson, R., Wilson, M., Weinberg, R., Sorci-Thomas, M.G. & Rudel, L.L. (2001) Is the oxidation of high-density lipoprotein lipids different than the oxidation of low-density lipoprotein lipids? Biochemistry, 40, 1719-1724.
32. Tsumura, M., Kinouchi, T., Ono, S., Nakajima, T. & Komoda, T. (2001) Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease. Clinica Chimica Acta, 314, 27-37.